Skip to main content
Have a personal or library account? Click to login
Comparison between whole-body MRI and Fluorine-18-Fluorodeoxyglucose PET or PET/CT in oncology: a systematic review Cover

Comparison between whole-body MRI and Fluorine-18-Fluorodeoxyglucose PET or PET/CT in oncology: a systematic review

Radiology and Oncology
Volume 47 (2013): Issue 3 (September 2013)
By: ,  ,  ,  ,  ,   and    
Open Access
|Jul 2013
References

References

  1. 1. Hodolic M. Role of F-18-choline PET/CT in evaluation of patients with prostate carcinoma.2011;17-21.
    Open DOISearch in Google Scholar
  2. 2. Basu S, Alavi A. Unparalleled contribution of 18F-FDG PET to medicine over 3 decades.2008;17N-21N, 37N.
    Search in Google Scholar
  3. 3. Wang X, Xu M, Liang H, Xu LS. Comparison of CT and MRI in diagnosis of cerebrospinal leak induced by multiple fractures of skull base.2011;: 91-6
    Open DOISearch in Google Scholar
  4. 4. Schmidt GP, Reiser MF, Baur-Melnyk A. Whole-body MRI for the staging and follow-up of patients with metastasis.2009;393-400.
    Open DOISearch in Google Scholar
  5. 5. Lambregts DM, Maas M, Cappendijk VC, Prompers LM, Mottaghy FM, Beets GL, et al. Whole-body diffusion-weighted magnetic resonance imaging: Current evidence in oncology and potential role in colorectal cancer staging.2011;2107-16.
    Open DOISearch in Google Scholar
  6. 6. Thomson V, Pialat JB, Gay F, Coulon A, Voloch A, Granier A, et al. Wholebody MRI for metastases screening: a preliminary study using 3D VIBE sequences with automatic subtraction between noncontrast and contrast enhanced images.2008;285-92.
    Open DOISearch in Google Scholar
  7. 7. Mürtz P, Krautmacher C, Träber F, Gieseke J, Schild HH, Willinek WA. Diffusion-weighted whole-body MR imaging with background body signal suppression: a feasibility study at 3.0 Tesla.2007;3031-7.
    Open DOISearch in Google Scholar
  8. 8. Seemann MD, Meisetschlaeger G, Gaa J, Rummeny EJ. Assessment of the extent of metastases of gastrointestinal carcinoid tumors using whole-body PET, CT, MRI, PET/CT and PET/MRI.2006;58-65.
    Search in Google Scholar
  9. 9. Furth C, Amthauer H, Denecke T, Ruf J, Henze G, Gutberlet M. Impact of whole-body MRI and FDG-PET on staging and assessment of therapy response in a patient with Ewing sarcoma.2006;607-11.
    Open DOISearch in Google Scholar
  10. 10. Yan RZ, Yang C, Zhang Q, Gu XM. [Whole-body diffusion weighted imaging manifestation of oral squamous cell carcinoma with metastatic lymph nodes]. [Chinese].2009;144-6.
    Search in Google Scholar
  11. 11. Wang JW, Zhao S, Liu Y, Li J, Xu LM. [Preliminary study on the validity of whole body diffusion-weighted imaging for the detection of malignant lesions]. [Chinese].2010;304-8.
    Search in Google Scholar
  12. 12. Lin C, Luciani A, Itti E, El-Gnaoui T, Vignaud A, Beaussart P, et al. Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma.2010;2027-38.
    Open DOISearch in Google Scholar
  13. 13. Schmidt GP, Baur-Melnyk A, Tiling R, Hahn K, Reiser MF, Schoenberg SO. [Comparison of high resolution whole-body MRI using parallel imaging and PET-CT. First experiences with a 32-channel MRI system.] [German].2004;889-98.
    Search in Google Scholar
  14. 14. Reiner CS, Fischer MA, Hany T, Stolzmann P, Nanz D, Donati OF, et al. Molecular imaging of malignant tumor metabolism: whole-body image fusion of DWI/CT vs. PET/CT.2011;940-6.
    Open DOISearch in Google Scholar
  15. 15. Ohno Y, Koyama H, Nogami M, Takenaka D, Yoshikawa T, Yoshimura M, et al. Whole-body MR imaging vs. FDG-PET: comparison of accuracy of M-stage diagnosis for lung cancer patients.2007;498-509.
    Open DOISearch in Google Scholar
  16. 16. Ng SH, Chan SC, Yen TC, Chang JT, Liao CT, Ko SF, et al. Pretreatment evaluation of distant-site status in patients with nasopharyngeal carcinoma: accuracy of whole-body MRI at 3-Tesla and FDG-PET-CT.2009;2965-76.
    Open DOISearch in Google Scholar
  17. 17. Antoch G, Vogt FM, Freudenberg LS, Nazaradeh F, Goehde SC, Barkhausen J, et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology.2003;3199-206.
    Open DOISearch in Google Scholar
  18. 18. Schmidt GP, Baur-Melnyk A, Herzog P, Schmid R, Tiling R, Schmidt M, et al. High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system.2005;743-53.
    Open DOISearch in Google Scholar
  19. 19. Komori T, Narabayashi I, Matsumura K, Matsuki M, Akagi H, Ogura Y, et al. 2-[Fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/ computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience.2007;209-15.
    Open DOISearch in Google Scholar
  20. 20. Li S, Sun F, Jin ZY, Xue HD, Li ML. Whole-body diffusion-weighted imaging: technical improvement and preliminary results.2007;1139-44.
    Open DOISearch in Google Scholar
  21. 21. Brauck K, Zenge MO, Vogt FM, Quick HH, Stock F, Trarbach T, et al. Feasibility of whole-body MR with T2- and T1-weighted real-time steady-state free precession sequences during continuous table movement to depict metastases.2008;910-6.
    Open DOISearch in Google Scholar
  22. 22. Yang TH, Lin JZ, Wang X, Lu JH, Chen Z. Preliminary study of feasibility of whole body diffusion weighted imaging in diagnosis of metastasis of tumor.2008;187-92.
    Open DOISearch in Google Scholar
  23. 23. Stecco A, Romano G, Negru M, Volpe D, Saponaro A, Costantino S, et al. Whole-body diffusion-weighted magnetic resonance imaging in the staging of oncologic patients: comparison with positron emission tomography computed tomography (PET-CT) in a pilot study.2009;1-17.
    Open DOISearch in Google Scholar
  24. 24. Krohmer S, Sorge I, Krausse A, Kluge R, Bierbach U, Marwede D, et al. Whole-body MRI for primary evaluation of malignant disease in children.2010;256-61.
    Open DOISearch in Google Scholar
  25. 25. Fischer MA, Nanz D, Hany T, Reiner CS, Stolzmann P, Donati OF, et al. Diagnostic accuracy of whole-body MRI/DWI image fusion for detection of malignant tumours: a comparison with PET/CT.2011;246-55.
    Open DOISearch in Google Scholar
  26. 26. Schmidt GP, Paprottka P, Jakobs TF, Hoffmann RT, Baur-Melnyk A, Haug A, et al. FDG-PET-CT and whole-body MRI for triage in patients planned for radioembolisation therapy.2012;269-76.
    Open DOISearch in Google Scholar
  27. 27. Cafagna D, Rubini G, Iuele F, Maggialetti N, Notaristefano A, Pinto D, et al. Whole-body MR-DWIBS vs. [(18)F]-FDG-PET/CT in the study of malignant tumors: a retrospective study.2012;293-311.
    Open DOISearch in Google Scholar
  28. 28. Manenti G, Cicciò C, Squillaci E, Strigari L, Calabria F, Danieli R, et al. Role of combined DWIBS/3D-CE-T1w whole-body MRI in tumor staging: Comparison with PET-CT.2012 doi:10.1016/j.ejrad.2011.08.005
    Open DOISearch in Google Scholar
  29. 29. Punwani S, Taylor SA, Bainbridge A, Prakash V, Bandula S, De Vita E, et al. Pediatric and adolescent lymphoma: comparison of whole-body STIR half- Fourier RARE MR imaging with an enhanced PET/CT reference for initial staging.2010;182-90.
    Open DOISearch in Google Scholar
  30. 30. van Ufford HM, Kwee TC, Beek FJ, van Leeuwen MS, Takahara T, Fijnheer R, et al. Newly diagnosed lymphoma: initial results with whole-body T1- weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG PET/ CT.2011;662-9.
    Open DOISearch in Google Scholar
  31. 31. Abdulqadhr G, Molin D, Aström G, Suurküla M, Johansson L, Hagberg H, et al. Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients.2011;173-80.
    Open DOISearch in Google Scholar
  32. 32. Gu J, Chan T, Zhang J, Leung AY, Kwong YL, Khong PL. Whole-body diffusionweighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma.2011;w384-91.
    Open DOISearch in Google Scholar
  33. 33. Lin C, Itti E, Luciani A, Zegai B, Lin SJ, Kuhnowski F, et al. Whole-body diffusion-weighted imaging with apparent diffusion coefficient mapping for treatment response assessment in patients with diffuse large B-cell lymphoma:pilot study.2011;341-9.
    Open DOISearch in Google Scholar
  34. 34. Wu X, Kellokumpu-Lehtinen PL, Pertovaara H, Korkola P, Soimakallio S, Eskola H, et al. Diffusion-weighted MRI in early chemotherapy response evaluation of patients with diffuse large B-cell lymphoma--a pilot study: comparison with 2-deoxy-2-fluoro-D-glucose-positron emission tomography/ computed tomography.2011;1181-90.
    Open DOISearch in Google Scholar
  35. 35. Chen Y, Zhong J, Wu H, Chen N. The clinical application of whole-body diffusion- weighted imaging in the early assessment of chemotherapeutic effects in lymphoma: the initial experience.2012;165-70.
    Open DOISearch in Google Scholar
  36. 36. Shortt CP, Gleeson TG, Breen KA, McHugh J, O’Connell MJ, O’Gorman PJ, et al. Whole-Body MRI versus PET in assessment of multiple myeloma disease activity.2009;980-6.
    Open DOISearch in Google Scholar
  37. 37. Daldrup-Link HE, Franzius C, Link TM, Laukamp D, Sciuk J, Jürgens H, et al. Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET.2001;229-36.
    Open DOISearch in Google Scholar
  38. 38. Schmidt GP, Schoenberg SO, Schmid R, Stahl R, Tiling R, Becker CR, et al. Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT.2007;939-49.
    Open DOISearch in Google Scholar
  39. 39. Ribrag V, Vanel D, Leboulleux S, Lumbroso J, Couanet D, Bonniaud G, et al. Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET/CT and bone marrow biopsy.2008;325-31.
    Open DOISearch in Google Scholar
  40. 40. Kumar J, Seith A, Kumar A, Sharma R, Bakhshi S, Kumar R, et al. Wholebody MR imaging with the use of parallel imaging for detection of skeletal metastases in pediatric patients with small-cell neoplasms: comparison with skeletal scintigraphy and FDG PET/CT.2008;953-62.
    Open DOISearch in Google Scholar
  41. 41. Takenaka D, Ohno Y, Matsumoto K, Aoyama N, Onishi Y, Koyama H, et al. Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy.2009;298-308.
    Open DOISearch in Google Scholar
  42. 42. Heusner T, Gölitz P, Hamami M, Eberhardt W, Esser S, Forsting M, et al. “One-stop-shop” staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?2011;430-5.
    Search in Google Scholar
  43. 43. Ng SH, Chan SC, Yen TC, Liao CT, Chang JT, Ko SF, et al. Comprehensive imaging of residual/ recurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT.2010;2229-40.
    Open DOISearch in Google Scholar
  44. 44. O’Neill JP, Moynagh M, Kavanagh E, O’Dwyer T. Prospective, blinded trial of whole-body magnetic resonance imaging versus computed tomography positron emission tomography in staging primary and recurrent cancer of the head and neck.2010;1274-7.
    Open DOISearch in Google Scholar
  45. 45. Ng SH, Chan SC, Yen TC, Liao CT, Lin CY, Tung-Chieh Chang J, et al. PET/CT and 3-T whole-body MRI in the detection of malignancy in treated oropharyngeal and hypopharyngeal carcinoma.2011;996-1008.
    Open DOISearch in Google Scholar
  46. 46. Chan SC, Wang HM, Yen TC, Lin CY, Chin SC, Liao CT, et al. 18F-FDG PET/ CT and 3.0-T whole-body MRI for the detection of distant metastases and second primary tumours in patients with untreated oropharyngeal/hypopharyngeal carcinoma: a comparative study.2011;1607-19.
    Open DOISearch in Google Scholar
  47. 47. Eiber M, Souvatzoglou M, Pickhard A, Loeffelbein DJ, Knopf A, Holzapfel K, et al. Simulation of a MR-PET protocol for staging of head-and-neck cancer including Dixon MR for attenuation correction.2012;2658-65.
    Open DOISearch in Google Scholar
  48. 48. Plathow C, Aschoff P, Lichy MP, Eschmann S, Hehr T, Brink I, et al. Positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced nonsmall cell lung cancer-initial results.2008;290-7.
    Open DOISearch in Google Scholar
  49. 49. Ohno Y, Koyama H, Onishi Y, Takenaka D, Nogami M, Yoshikawa T, et al. Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.2008;643-54.
    Open DOISearch in Google Scholar
  50. 50. Yi CA, Shin KM, Lee KS, Kim BT, Kim H, Kwon OJ, et al. Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging.2008;632-42.
    Search in Google Scholar
  51. 51. Chen W, Jian W, Li HT, Li C, Zhang YK, Xie B, et al. Whole-body diffusionweighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up?2010;613-70.
    Open DOISearch in Google Scholar
  52. 52. Pfannenberg C, Aschoff P, Schanz S, Eschmann SM, Plathow C, Eigentler TK, et al. Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma.2007;557-64.
    Open DOISearch in Google Scholar
  53. 53. Laurent V, Trausch G, Bruot O, Olivier P, Felblinger J, Régent D. Comparative study of two whole-body imaging techniques in the case of melanoma metastases: advantages of multi-contrast MRI examination including a diffusion-weighted sequence in comparison with PET-CT.2010;376-83.
    Open DOISearch in Google Scholar
  54. 54. Dellestable P, Granel-Brocard F, Rat AC, Olivier P, Régent D, Schmutz JL. [Impact of whole body magnetic resonance imaging (MRI) in the management of melanoma patients, in comparison with positron emission tomography/ computed tomography (TEP/CT) and CT.] [French].2011;377-83.
    Search in Google Scholar
  55. 55. Schmidt GP, Baur-Melnyk A, Haug A, Heinemann V, Bauerfeind I, Reiser MF, et al. Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT.2008;47-58.
    Open DOISearch in Google Scholar
  56. 56. Heusner TA, Kuemmel S, Koeninger A, Hamami ME, Hahn S, Quinsten A, et al. Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging.2010;1077-86.
    Open DOISearch in Google Scholar
  57. 57. Squillaci E, Manenti G, Mancino S, Cicciò C, Calabria F, Danieli R, et al. Staging of colon cancer: whole-body MRI vs. whole-body PET-CT--initial clinical experience.2008;676-88.
    Open DOISearch in Google Scholar
  58. 58. Schmidt GP, Baur-Melnyk A, Haug A, Utzschneider S, Becker CR, Tiling R, et al. Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer.2009;1366-78.
    Search in Google Scholar
  59. 59. Giraudet AL, Vanel D, Leboulleux S, Aupérin A, Dromain C, Chami L, et al. Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels.2007;4185-90.
    Open DOISearch in Google Scholar
  60. 60. Takano A, Oriuchi N, Tsushima Y, Taketomi-Takahashi A, Nakajima T, Arisaka Y, et al. Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with 18F-FDG positron emission tomography and 123I-MIBG scintigraphy.2008;395-401.
    Open DOISearch in Google Scholar
  61. 61. Plathow C, Walz M, Lichy MP, Aschoff P, Pfannenberg C, Bock H, et al. [Cost considerations for whole-body MRI and PET/CT as part of oncologic staging.] [German].2008;384-96.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/raon-2013-0007 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 206 - 218
Published on: Jul 30, 2013
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
positron emission tomography,
PET/CT,
fluorodeoxyglucose,
whole-body magnetic resonance imaging,
diffusion-weighted imaging,
oncology
Related subjects:
Medicine,
Clinical medicine,
Radiology

© 2013 Mario Ciliberto, Fabio Maggi, Giorgio Treglia, Federico Padovano, Lucio Calandriello, Alessandro Giordano, Lorenzo Bonomo, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 47 (2013): Issue 3 (September 2013)
Previous article
Next article